Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | BCL9 | O00512 | 1/20 | 0.49 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.42 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.42 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL409598 | 0.91 | HTR2A (0.59) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL125510 | 0.86 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL10062010 | 0.86 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL7477346 | 0.85 | HTR2A (0.54) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL763025 | 0.84 | HTR2A (0.57) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL2597458 | 0.84 | MGLL (0.59) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL4433836 | 0.84 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL14495241 | 0.84 | HTR2A (0.53) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL409084 | 0.84 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAMAPT | |
| SCHEMBL9223114 | 0.84 | HTR2A (0.60) | HTR2ABCL9CTNNB1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180237487-A1 | LECTIN COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN | OPSANITX LLC (US) | 2018-08-23 | — | — | US | disclosed |
| US-9951113-B2 | Lectin compositions and methods for modulating an immune response to an antigen | OPSANITX LLC (US) | 2018-04-24 | — | — | US | disclosed |
| US-20180015180-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC (CA) | 2018-01-18 | — | — | US | disclosed |
| US-20170088595-A1 | LECTIN COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN | GENITRIX, LLC | 2017-03-30 | — | — | US | disclosed |
| US-9597394-B2 | Lectin compositions and methods for modulating an immune response to an antigen | OPSANITX LLC (US) | 2017-03-21 | — | — | US | disclosed |
| EP-2588490-B1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC (CA) | 2017-02-22 | — | — | EP | disclosed |
| US-20160263236-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC (CA) | 2016-09-15 | — | — | US | disclosed |
| US-20150297715-A1 | LECTIN COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN | GENITRIX, LLC | 2015-10-22 | — | — | US | disclosed |
| US-20150174267-A1 | COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTIC AGENTS | ANGIOCHEM INC (CA) | 2015-06-25 | — | — | US | disclosed |
| US-8940307-B2 | Lectin compositions and methods for modulating an immune response to an antigen | OPSANITX LLC (US) | 2015-01-27 | — | — | US | disclosed |
| US-20040039156-A1 | Lectin compositions and methods for modulating an immune response to an antigen | OPSANITX LLC | 2004-02-26 | — | — | US | disclosed |
| US-6475516-B2 | HYDROGEL LOADED WITH LIPOSOMAL THERAPEUTIC AGENT | COVALON TECHNOLOGIES INC. (CA) | 2002-11-05 | — | — | US | disclosed |
| US-20020051812-A1 | Drug delivery via therapeutic hydrogels | DICOSMO FRANK (CA) | 2002-05-02 | — | — | US | disclosed |
| US-20020009485-A1 | Drug delivery via therapeutic hydrogels | COVALON TECHNOLOGIES INC. (CA) | 2002-01-24 | — | — | US | disclosed |
| US-6228393-B1 | HYDROGELS WITH LIPOSOMAL THERAPEUTIC AGENTS SUCH AS ANTIBIOTICS ARE COVALENTLY BONDED TO THE SURFACE OF SUBSTRATES, SUCH AS IN-DWELLING MEDICAL DEVICES, SUCH AS IMPLANTS, CATHETERS, | UROTEQ, INC. (CA) | 2001-05-08 | — | — | US | disclosed |
| EP-1079854-A1 | COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN | Genitrix LLC (US) | 2001-03-07 | — | — | EP | disclosed |
| US-6132765-A | VEHICLE FOR EFFECTING DRUG DELIVERY FROM SOLID SUBSTRATE; USEFUL IN TREATMENT AND PREVENTION OF BIOFILM MEDIATED INFECTION OFTEN ASSOCIATED WITH THE USE OF IN-DWELLING MEDICAL DEVICES, E.G. IMPLANTS, CATHETERS | UROTEQ INC. (CA) | 2000-10-17 | — | — | US | disclosed |
| EP-0984798-A2 | DRUG DELIVERY VIA THERAPEUTIC HYDROGELS | Uroteq Inc. (CA) | 2000-03-15 | — | — | EP | disclosed |
| WO-1999061051-A1 | COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN | GENITRIX, LCC (US) | 1999-12-02 | — | — | WO | disclosed |
| WO-1998046287-A2 | DRUG DELIVERY VIA THERAPEUTIC HYDROGELS | UROTEQ INC. (CA) | 1998-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180015180-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | SLC43A1, SLC7A5, DNPEP | HTR2A 3416/4885BCL9 590/4885CTNNB1 4456/4885 |
| US-20160263236-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | SLC43A1, SLC7A5, DNPEP | HTR2A 3416/4885BCL9 590/4885CTNNB1 4456/4885 |
| US-20150174267-A1 | COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTIC AGENTS | GBA1, SLC47A1, GAA | HTR2A 4465/4885BCL9 1086/4885CTNNB1 4537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.